NewGenIvf Group Limited
NIVF · NASDAQ
12/31/2024 | 9/30/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -13.5% | -3.1% | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 28.2% | 43.9% | 13% | – |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 4.6% | 15.4% | 29.7% | – |
| Net Income | -$0 | -$0 | -$0 | $0 |
| % Margin | -8.5% | -1.3% | -62.9% | – |
| EPS Diluted | -23.75 | -6.75 | 165.25 | 117.25 |
| % Growth | -251.9% | -104.1% | 40.9% | – |
| Operating Cash Flow | -$0 | – | -$0 | -$0 |
| Capital Expenditures | -$0 | – | -$0 | $0 |
| Free Cash Flow | -$0 | – | -$0 | -$0 |